Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Acquisitions (2020 - 2021)

Insight Molecular Diagnostics (IMDX) has disclosed Acquisitions for 2 consecutive years, with $607000.0 as the latest value for Q1 2021.

  • Quarterly Acquisitions fell 90.19% to $607000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $607000.0 through Dec 2021, down 90.19% year-over-year, with the annual reading at $607000.0 for FY2021, 90.19% down from the prior year.
  • Acquisitions hit $607000.0 in Q1 2021 for Insight Molecular Diagnostics, down from $6.2 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $6.2 million in Q1 2020 to a low of $607000.0 in Q1 2021.